Tan et al. discovered RAC1 strengthened radioresistance by enhancing EMT through PAK1-LIMK1-Cofilins signaling in lung cancer, indicating that RAC1 may serve as a potential treatment target in radioresistant lung cancer cells (Tan et al. 2020). Here, CFL1 is linked to lung cancer.